169 related articles for article (PubMed ID: 33245102)
1. FAM225A promotes sorafenib resistance in hepatocarcinoma cells through modulating miR-130a-5p-CCNG1 interaction network.
Liu YT; Liu GQ; Huang JM
Biosci Rep; 2020 Nov; 40(12):. PubMed ID: 33245102
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA SNHG16 induces sorafenib resistance in hepatocellular carcinoma cells through sponging miR-140-5p.
Ye J; Zhang R; Du X; Chai W; Zhou Q
Onco Targets Ther; 2019; 12():415-422. PubMed ID: 30655679
[TBL] [Abstract][Full Text] [Related]
3. lncRNA-POIR promotes epithelial-mesenchymal transition and suppresses sorafenib sensitivity simultaneously in hepatocellular carcinoma by sponging miR-182-5p.
Chen BW; Zhou Y; Wei T; Wen L; Zhang YB; Shen SC; Zhang J; Ma T; Chen W; Ni L; Wang Y; Bai XL; Liang TB
J Cell Biochem; 2021 Jan; 122(1):130-142. PubMed ID: 32951268
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA FAM225A Promotes Esophageal Squamous Cell Carcinoma Development and Progression via Sponging MicroRNA-197-5p and Upregulating NONO.
Zhu P; Huang H; Gu S; Liu Z; Zhang X; Wu K; Lu T; Li L; Dong C; Zhong C; Zhou Y
J Cancer; 2021; 12(4):1073-1084. PubMed ID: 33442405
[TBL] [Abstract][Full Text] [Related]
5. The lncRNA lnc-TSI antagonizes sorafenib resistance in hepatocellular carcinoma via downregulating miR-4726-5p expression and upregulating KCNMA1 expression.
Chen F; Jiang J; Liu D; Li H; Dong L; Song Y; Zhang Y; Wang J; Qin Y; Zhao G
J Mol Histol; 2024 Feb; 55(1):83-96. PubMed ID: 38165571
[TBL] [Abstract][Full Text] [Related]
6. [MicroRNA 424-5p promotes the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting Kinesin family member 23].
Liu XL; Sun CF; Yuan Y; Sheng YJ; Deng CL
Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1074-1081. PubMed ID: 36727232
[No Abstract] [Full Text] [Related]
7. LncRNA HEIH Confers Cell Sorafenib Resistance in Hepatocellular Carcinoma by Regulating miR-98-5p/PI3K/AKT Pathway.
Shen Q; Jiang S; Wu M; Zhang L; Su X; Zhao D
Cancer Manag Res; 2020; 12():6585-6595. PubMed ID: 32821157
[TBL] [Abstract][Full Text] [Related]
8. CircSCMH1 Accelerates Sorafenib Resistance in Hepatocellular Carcinoma by Regulating HN1 Expression via miR-485-5p.
Li M; Pang X; Xu H; Xiao L
Mol Biotechnol; 2024 Feb; ():. PubMed ID: 38372878
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles Mediated circROBO1 Silencing to Inhibit Hepatocellular Carcinoma Progression by Modulating miR-130a-5p/CCNT2 Axis.
Meng H; Li R; Xie Y; Mo Z; Zhai H; Zhang G; Liang G; Shi X; Zhou B
Int J Nanomedicine; 2023; 18():1677-1693. PubMed ID: 37020690
[TBL] [Abstract][Full Text] [Related]
10. Hsa_circ_0006988 Promotes Sorafenib Resistance of Hepatocellular Carcinoma by Modulating IGF1 Using miR-15a-5p.
Qiu R; Zeng Z
Can J Gastroenterol Hepatol; 2022; 2022():1206134. PubMed ID: 36594050
[TBL] [Abstract][Full Text] [Related]
11. MiR-21-5p promotes sorafenib resistance and hepatocellular carcinoma progression by regulating SIRT7 ubiquitination through USP24.
Hu Z; Zhao Y; Mang Y; Zhu J; Yu L; Li L; Ran J
Life Sci; 2023 Jul; 325():121773. PubMed ID: 37187452
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and modulating the downstream PTEN-PI3K/Akt pathway.
Li X; Yin X; Bao H; Liu C
Mol Cell Probes; 2023 Feb; 67():101877. PubMed ID: 36442661
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-92b augments sorafenib resistance in hepatocellular carcinoma via targeting PTEN to activate PI3K/AKT/mTOR signaling.
Cheng Z; Ni Q; Qin L; Shi Y
Braz J Med Biol Res; 2021; 54(9):e10390. PubMed ID: 34076140
[TBL] [Abstract][Full Text] [Related]
14. The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma.
Zhang Z; Tan X; Luo J; Yao H; Si Z; Tong JS
Cell Death Dis; 2020 Oct; 11(10):902. PubMed ID: 33097691
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NEAT1 modulates sorafenib resistance in hepatocellular carcinoma through regulating the miR-149-5p/AKT1 axis.
Niu Y; Tang G; Wu X; Wu C
Saudi J Gastroenterol; 2020 May; 26(4):194-203. PubMed ID: 32461380
[TBL] [Abstract][Full Text] [Related]
16. Targeted Delivery of Glypican 3 (GPC3) Antibody-Modified MicroRNA (miR let-7b-5p) Polymer Nanoparticles to Sorafenib-Resistant Hepatsocellular Carcinoma Cells.
Zhou S; Ma Y; Liu X; Yu P; Huang N; Song L; Xu R; Huo Z; Zhu T; Tang X
J Biomed Nanotechnol; 2021 Apr; 17(4):677-690. PubMed ID: 35057893
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma.
Dai C; Zhang Y; Xu Z; Jin M
Cancer Cell Int; 2020; 20():98. PubMed ID: 32256207
[TBL] [Abstract][Full Text] [Related]
18. Maternal embryonic leucine zipper kinase serves as a potential prognostic marker and leads to sorafenib chemoresistance modified by miR-142-5p in hepatocellular carcinoma.
Li H; Gai L; Wu Z; Li F
Mol Biol Rep; 2022 Apr; 49(4):3015-3024. PubMed ID: 35013864
[TBL] [Abstract][Full Text] [Related]
19. Mitophagy promotes sorafenib resistance through hypoxia-inducible ATAD3A dependent Axis.
Wu H; Wang T; Liu Y; Li X; Xu S; Wu C; Zou H; Cao M; Jin G; Lang J; Wang B; Liu B; Luo X; Xu C
J Exp Clin Cancer Res; 2020 Dec; 39(1):274. PubMed ID: 33280610
[TBL] [Abstract][Full Text] [Related]
20. Endoplasmic reticulum stress promotes sorafenib resistance via miR-188-5p/hnRNPA2B1-mediated upregulation of PKM2 in hepatocellular carcinoma.
Zhou B; Lu D; Wang A; Cui J; Zhang L; Li J; Fan L; Wei W; Liu J; Sun G
Mol Ther Nucleic Acids; 2021 Dec; 26():1051-1065. PubMed ID: 34786210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
